HCPCS Level II code G0480 represents definitive confirmatory drug testing using analytical methods capable of identifying individual drugs and distinguishing structural isomers, such as GC/MS and LC/MS. It requires internal standards in all samples and method-specific calibration and quality control, and it includes specimen validity testing for 1–7 drug classes. This code defines a high-complexity laboratory service used in clinical toxicology, substance use disorder management, occupational testing, and forensic or medico-legal contexts.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of the clinical and laboratory context for G0480, how payers commonly classify and reimburse definitive drug testing, typical sites of service, and which aspects of the test drive coding and billing decisions. The publication outlines benchmarks and common billing practices, explains the technical and quality-control elements that distinguish definitive testing from screening immunoassays, and summarizes implications for laboratory operations and documentation. Data not available in the input is noted where applicable.